MedPath
NMPA Approval

Levosalbutamol Hydrochloride Nebuliser Solution

国药准字H20223091

February 23, 2022

Drug Information

盐酸左沙丁胺醇雾化吸入溶液

吸入制剂

3ml:0.63mg(按C13H21NO3计)

化学药品

February 23, 2022

Company Information

Applicant Company

四川省成都高新区安泰五路566号

Manufacturing Company

成都市高新区安泰五路566号101车间吸入制剂生产线,成都市高新区安泰五路566号201车间吸入制剂生产线(溶液型)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸左沙丁胺醇雾化吸入溶液 - NMPA 批准文号 | MedPath